Delivery Order SPE2DB22D3501-SPE2DB25FUG73

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,870.58, is a firm fixed-price delivery order for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $31,074.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $4,116.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product "WEGOVY 0.5 MG/0.5 ML PEN 0.5ML" and has a firm fixed-price pricing type with a completion date of November 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $7,103.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialized medication, with a completion date of December 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation indicated. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,659.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with an ultimate completion date of April 16, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $39,205.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 4, 2025. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,095.00 firm fixed-price delivery order contract is for the provision of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 24, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,903.26, is a Delivery Order for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024 and is a Firm Fixed Price contract. The contract was not set aside for any specific business category. AmerisourceBergen...
This federal contract award, valued at $1,228.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,973.53 firm fixed-price delivery order is for the supply of WEGOVY 0.5 mg/0.5 ml pens. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUG73
    Delivery Order

This federal contract award, valued at $7,448.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.8ML, a medical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set aside for any specific business type. The company also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/24/25, 11:02 AM